Phil Landrigan, M.D.

Peditrician, Epidemiologist, TIFO Board

Phil Landrigan is a world-renowned pediatrician, public health physician, and epidemiologist. Dr. Landrigan is on TIFO's Board of Directors. His research uses the tools of epidemiology to elucidate connections between toxic chemicals and human health, especially the health of infants and children. His early studies of lead poisoning were among the first to demonstrate that lead is toxic to children even at very low levels, which contributed to the US government's decision to remove lead from paint and gasoline. His research defined children’s unique susceptibilities to pesticides and other chemicals and catalyzed fundamental revamping of US policy. Dr. Landrigan was Chair of the Department of Preventative Medicine (1990-2018) and Dean for Global Health (2010-2018) at Mount Sinai School of Medicine. He was involved in the medical and epidemiological follow-up of 20,000 rescue workers from the 9/11 attack. From 2015 to 2017, he co-chaired the Lancet Commission on Pollution & Health, which reported that pollution causes 9 million deaths annually. Dr. Landrigan is the Director of the Global Observatory on Pollution and Health at Boston College. He served as President of the Collegium Ramazzini, an international academy of experts in the fields of occupational and environmental health, for more than 20 years.